“ Overall, programmatic mechanisms offer a coherent conceptual framework that fits the current empirical data, including species differences in aging and longevity manipulations in animal models .”
BUFFALO, NY — August 6, 2026 — A new research perspective was published in Volume 18 of Aging on July 24, 2026, titled “ A brief history of the hyperfunction theory of aging and future directions .”
The article was written by João Pedro de Magalhães from the Genomics of Ageing and Rejuvenation Lab, Department of Inflammation and Ageing, College of Medicine and Health, University of Birmingham, United Kingdom .
Rather than presenting new experimental findings, the perspective examines the historical development of the hyperfunction theory of aging, reviews evidence supporting programmatic mechanisms of aging, and discusses future directions for understanding why organisms age and how aging might eventually be modified.
For decades, most aging research has been dominated by the idea that aging results primarily from the gradual accumulation of molecular damage, including DNA damage, oxidative stress, mitochondrial dysfunction, and protein deterioration. In contrast, the hyperfunction theory proposes that aging is driven largely by developmental and growth programs that continue operating beyond their beneficial period. Rather than being intentionally programmed, aging is viewed as a consequence of biological pathways that promote growth and reproduction early in life but become harmful when they continue later in adulthood.
The perspective traces the historical roots of these ideas from early theories proposed in the nineteenth century through Clive McCay’s pioneering caloric restriction experiments and George Williams’ concept of antagonistic pleiotropy. Particular attention is given to the contributions of the late Mikhail Blagosklonny , whose hyperfunction theory proposed that aging results from “quasi-programs”—developmental processes that fail to switch off after their normal biological role has ended. The author argues that this framework provides a mechanistic explanation linking evolutionary theory with many biological features of aging.
The article also reviews experimental observations that have strengthened interest in programmatic aging. Studies demonstrating that single-gene manipulations can substantially extend lifespan in animal models, together with evidence that reduced growth hormone and insulin-like growth factor-1 (IGF-1) signaling can slow aging in mice and that rapamycin inhibits TOR signaling and extends lifespan, are presented as important support for the hyperfunction framework. Likewise, caloric restriction is discussed as another intervention whose lifespan-extending effects are more consistent with regulated biological processes than with aging driven solely by passive damage accumulation. At the same time, the author acknowledges that molecular damage clearly contributes to diseases such as cancer and likely interacts with programmatic mechanisms during aging rather than being entirely independent of them.
Looking ahead, the perspective highlights several research directions that could help distinguish competing theories of aging. The author argues that studying developmental biology alongside aging may reveal how genetic programs governing growth, tissue repair, and regeneration later contribute to functional decline. Emerging rejuvenation approaches, including partial cellular reprogramming, are also discussed as potentially powerful tests of the hyperfunction theory because they aim to reset biological age through changes in gene regulation rather than by simply repairing accumulated molecular damage. The perspective suggests that identifying tissue-specific rejuvenation programs could eventually lead to interventions capable of restoring function while minimizing unwanted effects such as increased cancer risk.
“ The hyperfunction framework developed by Blagosklonny, and the elegant term hyperfunction itself, provide a powerful and underappreciated lens through which to understand aging. ”
The author also emphasizes that important questions remain unresolved. Programmatic theories must still be tested experimentally, their molecular mechanisms further defined, and their relevance to human aging established. The perspective notes that aging is likely influenced by both developmental programs and molecular damage, with their relative contributions varying across tissues and diseases. Future work integrating developmental biology, genetics, epigenetics, and regenerative medicine will be essential for determining how these processes interact throughout life.
Overall, this research perspective presents a comprehensive overview of an influential but still underappreciated conceptual framework in modern aging biology. By placing decades of theoretical and experimental work into historical context, the article argues that developmental programs continuing beyond their adaptive role may represent a fundamental driver of aging. While additional empirical evidence is needed, the perspective suggests that understanding and selectively modifying these biological programs could become an important direction for future longevity research and the development of interventions that promote healthy aging.
Paper DOI : https://doi.org/10.18632/aging.206403
Corresponding author: João Pedro de Magalhães – jp@senescence.info
Keywords: antagonistic pleiotropy, longevity, programmatic aging, quasi-program
Click here to sign up for free Altmetric alerts about this article.
______
To learn more about the journal, please visit www.Aging-US.com and connect with us on social media:
Click here to subscribe to Aging publication updates.
For media inquiries, please contact media@impactjournals.com .
Aging-US
News article
Not applicable
A brief history of the hyperfunction theory of aging and future directions
24-Jul-2026
JPM is CSO of YouthBio Therapeutics, a company developing rejuvenation gene therapies based on partial reprogramming, an advisor/consultant for the BOLD Longevity Growth Fund and NOVOS, and the founder of Magellan Science Ltd, a company providing consulting services in longevity science.